Stocks
Becton, Dickinson and CompanyBDX
NYSEHealthcareMedical Devices$159.36-0.17%
A global medical technology manufacturer focused on products used in medication delivery, diagnostic testing, and bioscience research. Its portfolio includes syringes, needles, infusion systems, diagnostic instruments, and laboratory tools widely used by hospitals, laboratories, and pharmaceutical c...
Market Cap: $57.7B52W Range: $127.59 – $187.35
Congressional Interest in Becton, Dickinson and Company (BDX)
15 members of Congress have disclosed 50 trades in Becton, Dickinson and Company (BDX), a Healthcare company. The buy/sell breakdown shows 18 purchases versus 32 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
15
Buys
18
Sells
32
Who in Congress Is Trading BDX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-01-28 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2021-12-27 | MICHAEL T. MCCAUL | sell | $15K – $50K |